RESEARCH
Glycan Group – Recherche et développement
Expertise of Dr Christian Daniel Assoun with SILICON compounds since 1968
Dr. Christian Daniel Assoun realizes works on the properties of Silicon – in 1968 produced comment in the review of Bio mathematical presenting the CERENKOV effect like depriving phenomenon to occur in the brain and making possible the comprehension of biological mechanisms quantum-type phenomena can now enter the framework of neuroscience., in 1982 Dr. Christian Daniel Assoun writes a communication project CRAS at the Academy of Sciences (the quanta of biological origin basis of the genetic information, in 1975 and 1977 Dr. Christian files and obtains a first patent of electrochemistry using silicon crystal France and United Kingdom, another patent in 2002 implementing silicon will be deposited in France.- Dr. Assoun was the first researcher to carry out a research of toxicity on the animal (mouse) LD 50 University of Nice (Pharmacology) – 1985 targeted on several metals including Silicon Crystal – these studies led to prove Silicon hydrated SiO2 or Orthosilicic acid Si (OH) 4 is devoid of toxicity, others patents are registered 19.06.2019 Luxembourg and USA 25.07.2019 (Alzheimer Disease).
Depuis 1996, Glycan Industries LTD (UK) a développé plusieurs technologies avec des applications immédiates dans les domaines de la nutrition fonctionnelle, médecine et industries très spécialisées, en collaboration avec les Universités. Certaines de ces activités seront développées pour la recherche spatiale: glycanspacexr-agency.com
Deux instituts de recherche américains ont été créés en 2016 à Pasadena, USA.
ÅMERICAN INSTITUTE FOR QUANTUM SCIENCES AND PLASMA TECHNOLOGIES